Biogen Idec Inc. · Weston, MA United States (NASDAQ: BIIB)
Key Biogen Idec Inc. Financials
| Company Type | Public -(NASDAQ: BIIB) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | $5,048.6 |
| 2011 Employees | 5,000 |
Biogen Idec Inc. Income Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Revenue | 5,048.6 | 4,716.4 | 4,377.3 |
| Cost of Goods Sold | 466.8 | 400.3 | 382.1 |
| Gross Profit | 4,581.9 | 4,316.2 | 3,995.2 |
| Gross Profit Margin | 90.8% | 91.5% | 91.3% |
| SG&A Expense | 1,373.9 | 1,289.6 | 1,126.9 |
| Depreciation & Amortization | 208.6 | 208.9 | 289.8 |
| Operating Income | 1,724.7 | 1,248.9 | 1,295.4 |
| Operating Margin | 34.2% | 26.5% | 29.6% |
| Nonoperating Income | 0.3 | (5.2) | 24.6 |
| Nonoperating Expenses | (13.8) | (13.8) | 12.7 |
| Income Before Taxes | 1,711.2 | 1,229.9 | 1,332.7 |
| Income Taxes | 444.5 | 331.3 | 355.6 |
| Net Income After Taxes | 1,266.7 | 898.6 | 977.1 |
| Continuing Operations | 1,234.4 | 1,005.3 | 970.1 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1,234.4 | 1,005.3 | 970.1 |
| Total Net Income | 1,234.4 | 1,005.3 | 970.1 |
| Net Profit Margin | 24.5% | 21.3% | 22.2% |
| Diluted EPS from Total Net Income | 5.04 | 3.94 | 3.35 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Biogen Idec Inc. Balance Sheet
| Assets | Dec 11 | Dec 10 | Dec 09 |
| Current Assets | |||
| Cash | 514.5 | 759.6 | 581.9 |
| Net Receivables | 813.3 | 827.8 | 745.0 |
| Inventories | 326.8 | 289.1 | 294.0 |
| Other Current Assets | 1,320.7 | 664.0 | 859.8 |
| Total Current Assets | 2,975.4 | 2,540.4 | 2,480.6 |
| Net Fixed Assets | 1,571.4 | 1,641.6 | 1,637.1 |
| Other Noncurrent Assets | 4,502.8 | 3,910.4 | 4,434.2 |
| Total Assets | 9,049.6 | 8,092.5 | 8,551.9 |
| Liabilities | Dec 11 | Dec 10 | Dec 09 |
| Current Liabilities | |||
| Accounts Payable | 186.4 | 162.5 | 118.5 |
| Short-Term Debt | 3.3 | 137.2 | 19.8 |
| Other Current Liabilities | 723.1 | 750.4 | 576.6 |
| Total Current Liabilities | 912.9 | 1,050.1 | 714.9 |
| Long-Term Debt | 1,060.8 | 1,066.4 | 1,080.2 |
| Other Noncurrent Liabilities | 650.4 | 579.5 | 535.2 |
| Total Liabilities | 2,624.1 | 2,696.0 | 2,330.3 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | -- | 0.0 |
| Common Stock Equity | 6,425.5 | 5,396.5 | 6,221.5 |
| Total Equity | 6,425.5 | 5,396.5 | 6,221.5 |
| Shares Outstanding (thou.) | 242,115.0 | 240,538.0 | 274,855.0 |
All amounts in millions of US Dollars except per share amounts.
Biogen Idec Inc. Cash Flow Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Net Operating Cash Flow | 1,728 | 1,625 | 1,075 |
| Net Investing Cash Flow | (1,650.3) | 345.3 | (395.0) |
| Net Financing Cash Flow | (319.9) | (1,784.9) | (724.2) |
| Net Change in Cash | (242.4) | 185.1 | (44.3) |
| Depreciation & Amortization | 208.6 | 208.9 | 289.8 |
| Capital Expenditures | (252.2) | (173.1) | (165.6) |
| Cash Dividends Paid | (27.1) | (23.5) |
All amounts in millions of US Dollars except per share amounts.